While NIH’s guidelines committee was presented with a mound of data, which resulted in a change of recommendation from ‘against‘ its use for Covid to ‘neutral‘ on use, major efforts elsewhere were made to stop the use of ivermectin for Covid.
The FDA, European Medicines Agency and the WHO have all issued statements in the past 2 months recommending against the use of ivermectin, without a clear rationale.
Twice in the past week I have had a pharmacist refuse to fill a script for ivermectin for patients. They said they were using their best judgement and there was no authority forcing them to restrict it. One cited the WHO guidance. So far, no official channels have clamped down, but this could happen any day. Please share the information and consider obtaining a supply so that this most effective medicine will be available if someone in your family develops Covid.
On the other hand, while the equivalent of the FDA in South Africa (SAHPRA) prohibited the use of ivermectin on December 24, they were taken to court over it. The case finally concluded–our side won!!!!– and as of today ivermectin is freely available to treat Covid in South Africa. Kudos to the legal team, doctors and plaintiffs who brought this action! Thanks to PANDA for keeping us informed and for its work on the cases.
Update April 7: Article on the South African legal battle for ivermectin use.
Meanwhile, the BMGF’s U Washington team published another computational analysis of drug repurposing for Covid. Ivermectin just missed the cut. They modelled a “better” ivermectin alternative. Unfortunately, their #1 drug has never been used in humans, so actually testing it and getting it approved could take quite a while. Which would suit BMGF just fine, I guess.
On April 11, the WSJ published a letter by Senator Ron Johnson and Professor Harvey Risch about the desperate need to use repurposed drugs for Covid.